Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IronHIFs-HF: Iron Deficiency Pilot Trial in Heart Failure
jRCTs051230146Recruiting
- Sponsor
- Actelion Pharmaceuticals Ltd
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of daprodustat and sodium ferrous citrate in heart failure (HF) and iron deficiency anemia (IDA) (2 arms), sponsored by Actelion Pharmaceuticals Ltd. Primary endpoint: Change in Short Physical Performance Battery (SPPB) total score at 3 months. Started Sep 2024; status: recruiting.
02
Drugs
daprodustatsodium ferrous citrate
03
Conditions
heart failure (HF)iron deficiency anemia (IDA)
Beyond the preview
Go deeper on jRCTs051230146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051230146.